Tachyphylaxis to 5-HT3-receptor-mediated activation of vagal afferents is prevented by co-activation of 5-HT2 receptors

Brain Research

Volumn 1093, Issue 1, 2006, Pages 105-115

  Lacolley, Patrick J ^a   Owen, Joy R ^b   Bates, James N ^a   Johnson, Alan Kim ^a,c   Lewis, Stephen J ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c E11 SSH   (United States)

Author keywords

5 HT3 receptors; Rat; Serotonin (5 HT); Tachyphylaxis; Vagal afferents

Indexed keywords

2 METHYLSEROTONIN; ALPHA METHYLSEROTONIN; PHENYLBIGUANIDE; SEROTONIN 2 AGONIST; SEROTONIN 2 RECEPTOR; SEROTONIN 3 AGONIST; SEROTONIN 3 RECEPTOR; SEROTONIN AGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEZOLD JARISCH REFLEX; CONTROLLED STUDY; DESENSITIZATION; HEMODYNAMICS; MALE; NERVE STIMULATION; NEUROMODULATION; NEUROPHARMACOLOGY; NONHUMAN; PHARMACODYNAMICS; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY; REFLEX; SENSORY NERVE CELL; SEROTONINERGIC SYSTEM; TACHYPHYLAXIS; VAGUS NERVE; ANIMAL; DRUG EFFECT; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; HEMODYNAMIC PROCESSES; MALE; NEURONS, AFFERENT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN, 5-HT2; RECEPTORS, SEROTONIN, 5-HT3; REFLEX; SEROTONIN AGONISTS; TACHYPHYLAXIS; VAGUS NERVE;

EID: 33745343211     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.03.090     Document Type: Article

References (61)

1. Abdel-Latif A.A. Calcium-mobilizing receptors, polyphosphoinositols, and the generation of second messengers. Pharmacol. Rev. 38 (1986) 227-272
2. Andrade R., and Chaput Y. The electrophysiology of serotonin receptor subtypes. In: Petrouka S.J. (Ed). Serotonin Receptor Subtypes: Basic and Clinical Aspects (1991), John Wiley Ltd., New York, NY 103-124
3. Barres C., Lewis S.J., Jacob H.J., and Brody M.J. Arterial pressure lability and renal sympathetic nerve activity are dissociated in SAD rats. Am. J. Physiol. 203 (1992) R639-R646
4. Buchheit K.H., Costal B., Engel G., Gunning S.J., Naylor R.J., and Richar T. 5-HT receptor antagonism by metoclopramide and ICS 205-930 in the guinea-pig leads to enhancement of contractions of stomach muscle strips induced by electrical field stimulation and facilitation of gastric emptying in vivo. J. Pharm. Pharmacol. 37 (1985) 664-667
5. 3 receptor antagonists block morphine- and nicotine- but not amphetamine-induced reward. Psychopharmacology 97 (1989) 175-178
6. Christian E.P., Taylor G.E., and Weinreich D. Serotonin increases excitability of rabbit C-fiber neurons by two distinct mechanisms. J. Appl. Physiol. 67 (1989) 584-591
7. Costall B., Domeney A., Gerrard P., Kelly M., and Naylor R.J. Zacopride: anxiolytic profile in rodent and primate models of anxiety. J. Pharm. Pharmacol. 40 (1988) 302-305
8. Costall B., Domeney A., Gerrard P., Kelly M., Naylor R.J., and Tyers M.B. Inhibition by odansetron of behavioral effects in the rat which follow withdrawal for treatment of drugs of abuse. Br. J. Pharmacol. 96 (1989) 340 (Abstract)
9. Costall B., Jones B.J., Kelly M.E., Naylor R.J., Oakley N.R., Onavi E.S., and Tyers M.B. The effects of ondansetron (GR 38032F) in rats and mice treated subchronically with diazepam. Pharmacol. Biochem. Behav. 34 (1989) 769-778
10. 3 receptor agonists and antagonists for alteration of adverse behaviour in the mouse. Br. J. Pharmacol. 96 (1989) 325 (Abstract)
11. Dabire H., Cherqui C., Safar M., and Schmitt H. Haemodynamic aspects and serotonin. Clin. Physiol. Biochem. 3 Suppl. 3 (1990) 56-63
12. Davisson R.L., Bates J.N., Johnson A.K., and Lewis S.J. Use-dependent loss of acetylcholine and bradykinin-mediated vasodilation following nitric oxide synthase inhibition: evidence for preformed stores of nitric oxide-containing factors in vascular endothelial cells. Hypertension 28 (1996) 354-360
13. Davisson R.L., Shaffer R.A., Johnson A.K., and Lewis S.J. Use-dependent loss of active sympathetic neurogenic vasodilation following nitric oxide synthase inhibition in conscious rats: evidence for the presence of preformed stores of nitric oxide-containing factors. Hypertension 28 (1996) 347-353
14. Davisson R.L., Travis M.D., Bates J.N., and Lewis S.J. Hemodynamic effects of l- and d-S-nitrosocysteine in the rat: stereoselective S-nitrosothiol recognition sites. Circ. Res. 79 (1996) 256-262
15. 3 receptors are membrane ion-channels. Nature 339 (1989) 706-709
16. 2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositol phospholipid hydrolysis. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 2187-2191
17. Fenuik W., and Humphrey P.P.A. Mechanisms of 5-hydroxytryptamine-induced vasoconstriction. In: Fozard J.R. (Ed). The Peripheral Actions of 5-Hydroxytryptamine (1989), Oxford Univ. Press, Oxford 100-122
18. Fozard J.R. Neuronal 5-HT receptors in the periphery. Neuropharmacology 23 (1984) 1473-1486
19. 3 receptors. In: Saxena P.R., Wallis D.I., Wouters W., and Bevan P. (Eds). Cardiovascular Pharmacology of 5-Hydroxytryptamine (1990), Kluwer, Dordrecht, The Netherlands 101-115
20. 3 antagonist. Neurosci. Letts. 95 (1988) 313-317
21. 3 antagonist GR38032F (odansetron) on benzodiazepine withdrawal in rats. Eur. J. Pharmacol. 185 (1990) 179-186
22. Hartig P.R. Molecular biology of serotonin receptors. Trends Pharmacol. Sci. 10 (1992) 64-69
23. Hartig P.R., Kao H.T., Macchi M., Adham N., Zgombick J., Weinshank R., and Branchek T. The molecular biology of serotonin receptors: an overview. Neuropsychopharmacology 3 (1990) 335-347
24. Hausdorff W.P., Caron M.G., and Lefkowitz R.J. Turning off the signal: desensitization of β-adrenergic receptor function. FASEB J. 4 (1990) 2881-2889
25. Hollenberg N.K. Serotonin and vascular responses. Annu. Rev. Pharmacol. Toxicol. 28 (1988) 41-59
26. Jacob H.J., Alper R.H., Grosskreutz C.L., Lewis S.J., and Brody M.J. Vascular tone influences arterial pressure lability after sinoaortic deafferentation. Am. J. Physiol. 260 (1991) R359-R367
27. Ignarro L.J. Nitric oxide: a novel signal transduction mechanism for transcellular communication. Hypertension 16 (1990) 477-483
28. Julius D. Molecular biology of serotonin receptors. Annu. Rev. Neurosci. 14 (1991) 335-360
29. 2 receptor defines a family of structurally distinct but functionally conserved serotonin receptors. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 928-932
30. Kooy N.W., and Lewis S.J. Nitrotyrosine attenuates the hemodynamic effects of adrenoceptor agonists in vivo: relevance to the pathophysiology of peroxynitrite. Eur. J. Pharmacol. 310 (1996) 155-161
31. Lacolley P.J., Lewis S.J., and Brody M.J. The cardiovascular effects of blood-borne serotonin (5-HT) involve the nodose ganglia. The FASEB J. 4 (1990) A1107 (Abstract)
32. 2-receptors exist on rat vagal afferent perikarya. Soc. Neurosci. 16 (1990) 1280 (Abstract)
33. Lamb F.S., and Barna T.J. The endothelium modulates the contribution of chloride currents to norepinephrine-induced vascular contraction. Am. J. Physiol. 275 (1988) H161-H168
34. Lamb F.S., and Barna T.J. Chloride ion currents contribute functionally to norepinephrine-induced vascular contraction. Am. J. Physiol. 275 (1998) H151-H160
35. 3 receptors in clonal cell lines studied by patch-clamp techniques. Br. J. Pharmacol. 97 (1989) 27-40
36. Larijani G.E., Gratz I., and Afshar M. Treatment of post-operative nausea and vomiting with ondansetron: a randomized, double-blind comparison with placebo. Anesth. Analg. 73 (1991) 246-249
37. 3 receptor antagonist) in prevention of chemotherapy-induced emesis. Lancet 1 (1987) 1198
38. Lewis S.J., Barres C., Jacob H.J., Ohta H., and Brody M.J. Cardiovascular effects of the N-methyl-d-aspartate receptor antagonist MK-801 in conscious rats. Hypertension 13 (1989) 759-765
39. Lewis S.J., Verberne A.J.M., Beart P.M., Jarrott B., Louis C., and Louis W.J. Histological and functional evidence for a degeneration of vagal afferent neurons following application of the excitotoxin kainic acid to the nodose ganglion. Neuroscience 34 (1989) 331-339
40. 3 receptor, a serotonin-gated channel. Science 254 (1991) 432-437
41. 3 receptor subtypes. Brain Res. 561 (1991) 61-68
42. Meller S.T., Lewis S.J., Brody M.J., and Gebhart G.F. Vagal afferent-mediated inhibition of a nociceptive reflex by i.v. serotonin in the rat: II. Role of 5-HT receptor subtypes. Brain Res. 585 (1992) 71-86
43. Muntzel M.S., Lewis S.J., and Johnson A.K. Anteroventral third ventricle lesions attenuate pressor responses to serotonin in anesthetized rats. Brain Res. 714 (1996) 104-110
44. Myers P.R., Minor Jr. R.L., Guerra Jr. R., Bates J.N., and Harrison D.G. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 345 (1990) 161-163
45. 3 receptor-mediated electrical responses in cultured mouse neuroblastoma cells. Neuropharmacology 27 (1988) 301-307
46. Palczewski K., and Benovic J.L. G-protein-coupled receptor kinases. Trends Biol. Sci. 16 (1991) 387-391
47. 3 receptors in neuronal cell lines. Trends Pharmacol. Sci. 10 (1989) 172-173
48. 2 antagonist ICI 169,369 activates vagal afferents and in addition has a central hypotensive action in anesthetized rats. J. Auton. Pharmacol. 10 (1990) 345-351
49. Premont R.T., Inglese J., and Lefkowitz R.J. Protein kinases that phosphorylate activated G protein-coupled receptors. FASEB J. 9 (1995) 175-182
50. 2 receptor, EMBO J. 7 (88) 4135-4140.
51. Probst W.C., Snyder L.A., Schuster D.I., Brosius J., and Sealfon S.C. Sequence alignment of the G-protein coupled receptor superfamily. DNA and Cell Biol. 11 (1992) 1-20
52. 3 receptors. Trends Neurosci. 9 (1986) 424-428
53. Rosenblum W.I. Endothelium-derived relaxing factor in brain blood vessels is not nitric oxide. Stroke 23 (1992) 1527-1535
54. Satake N., Kiyoto S., Shibata S., Gandhi V., Jones D.J., and Morikawa M. Possible mechanisms of inhibition with atropine against noradrenaline-induced contraction in the rabbit aorta. Br. J. Pharmacol. 107 (1992) 553-558
55. Saxena P.R., Wallis D.I., Wouters W., and Bevan P. The Cardiovascular Pharmacology of 5-Hydroxytryptamine (1989), Kluwer, Dordrecht, The Netherlands
56. Thoren P. Role of cardiac vagal C-fibers in cardiovascular control. Rev. Physiol., Biochem. Pharmacol. 86 (1979) 1-94
57. 3 antagonists in laboratory animals. Neurosci. Letts. 29 (1987) S68 (Abstract)
58. 125I]-pindolol binding to β-adrenoceptors on rat nodose ganglion after chronic isoprenaline treatment. J. Auton. Nerv. Syst. 60 (1996) 12-16
59. 3 receptors on vagal afferents mediating the Bezold-Jarisch reflex. Brain Res. 873 (2000) 302-305
60. Yoshioka M., Ikeda T., Abe M., Togashi H., Minami M., and Saito H. Pharmacological characterization of 5-hydroxytryptamine-induced excitation of afferent cervical vagus nerve in anaesthetized rats. Br. J. Pharmacol. 106 (1992) 544-549
61. Zifa E., and Fillion G. 5-Hydroxytryptamine receptors. Pharmacol. Rev. 44 (1992) 401-458